AAPL 190.415 0.3663% MSFT 422.65 -0.1016% GOOG 175.36 0.8512% GOOGL 174.14 0.9449% AMZN 185.71 -0.1505% NVDA 943.46 -0.3001% META 473.555 -1.6582% TSLA 174.87 0.5058% TSM 154.06 -0.977% LLY 776.1758 -1.3779% V 280.145 -0.2972% AVGO 1436.4972 0.0228% JPM 204.205 1.0366% UNH 522.225 0.9033% NVO 133.03 -1.2105% WMT 63.485 6.109% LVMUY 170.79 -0.2511% XOM 117.87 -0.5988% LVMHF 855.728 -0.1473% MA 461.6867 0.805%

AptarGroup Inc

Healthcare US ATR


Last update at 2024-05-16T16:51:00Z

Day Range


52 Week Range



Income Statement


Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 334.70M 321.65M 301.15M 342.07M 266.02M
Minority interest -0.26700M 0.46M 0.40M 0.03M 0.32M
Net income 239.29M 244.10M 214.04M 242.20M 194.75M
Selling general administrative 544.26M 551.24M 500.23M 454.62M 429.95M
Selling and marketing expenses - - 500.23M - -
Gross profit 1163.84M 1156.68M 1086.52M 1041.33M 951.80M
Reconciled depreciation 233.71M 234.85M 220.30M 194.55M 171.75M
Ebit 379.27M 347.35M 339.50M 371.69M 362.48M
Ebitda 617.94M 605.32M 581.19M 592.58M 534.22M
Depreciation and amortization 238.67M 257.98M 241.69M 220.89M 171.75M
Non operating income net other - - - 5.87M 12.38M
Operating income 379.27M 347.35M 339.50M 371.69M 286.27M
Other operating expenses 2936.38M 2856.63M 2563.35M 2467.57M 2414.66M
Interest expense 40.83M 30.28M 33.24M 35.49M 32.63M
Tax provision 95.15M 78.02M 87.06M 99.84M 71.25M
Interest income 2.70M 22.60M 0.96M 4.17M 7.06M
Net interest income -38.12700M -26.61600M -32.28600M -31.31500M -25.57000M
Extraordinary items - - - 0.00000M 5.40M
Non recurring - - - 20.47M 63.83M
Other items - - - - -
Income tax expense 95.15M 78.02M 87.06M 99.84M 71.25M
Total revenue 3322.25M 3227.22M 2929.34M 2859.73M 2764.76M
Total operating expenses 777.97M 786.10M 720.53M 649.17M 601.70M
Cost of revenue 2158.41M 2070.54M 1842.82M 1818.40M 1812.96M
Total other income expense net -44.56900M -25.69300M -38.34300M -29.62400M -58.50800M
Discontinued operations - - - - -
Net income from continuing ops 239.56M 243.64M 214.09M 242.23M 194.77M
Net income applicable to common shares 239.29M 244.10M 214.04M 242.20M 194.75M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 4203.46M 4141.36M 3990.05M 3562.12M 3377.74M
Intangible assets 315.74M 362.34M 344.31M 291.08M 254.90M
Earning assets - - - - -
Other current assets 124.77M 121.73M 122.61M 115.05M 118.25M
Total liab 2135.25M 2156.76M 2139.27M 1989.87M 1954.86M
Total stockholder equity 2053.93M 1969.41M 1850.39M 1571.92M 1422.56M
Deferred long term liab - - - 142.61M 116.24M
Other current liab 393.99M 320.65M 331.67M 293.47M 292.90M
Common stock 0.71M 0.70M 0.69M 0.69M 0.67M
Capital stock 0.71M 0.70M 0.69M 0.69M 0.67M
Retained earnings 1929.24M 1789.41M 1643.83M 1523.82M 1371.83M
Other liab 122.53M 267.25M 251.73M 165.86M 139.70M
Good will 945.63M 974.16M 898.52M 763.46M 712.10M
Other assets 57.14M 533.12M 59.55M 47.88M 62.87M
Cash 141.73M 122.92M 300.14M 241.97M 261.82M
Cash and equivalents 141.73M 122.92M 300.14M 241.97M 261.82M
Total current liabilities 917.18M 982.49M 780.33M 683.27M 689.17M
Current deferred revenue 80.11M 86.95M 87.05M 86.82M 67.78M
Net debt 1033.66M 1073.73M 872.73M 953.73M 1028.14M
Short term debt 122.79M 289.63M 117.87M 110.25M 163.97M
Short long term debt 122.79M 285.88M 117.87M 110.25M 163.97M
Short long term debt total 1175.39M 1196.65M 1172.86M 1195.70M 1289.96M
Other stockholder equity 465.35M 495.33M 487.58M 389.36M 360.56M
Property plant equipment 1402.34M 1275.88M 1268.59M 1087.68M 991.61M
Total current assets 1430.29M 1358.21M 1368.99M 1291.24M 1330.81M
Long term investments 52.31M 59.48M 50.09M 8.40M 25.45M
Net tangible assets 792.56M 995.25M 607.56M 1627.19M 455.56M
Short term investments 89.42M 0.74M 0.24M - -
Net receivables 676.99M 671.35M 566.62M 558.43M 569.63M
Long term debt 1052.60M 907.02M 1055.00M 1085.45M 1125.99M
Inventory 486.81M 441.46M 379.38M 375.80M 381.11M
Accounts payable 320.28M 285.26M 243.74M 192.74M 164.53M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - 0.34M 0.32M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -341.36600M -316.04100M -281.70900M -341.94800M -310.50400M
Additional paid in capital - - - - -
Common stock total equity - - 0.69M 0.69M 0.67M
Preferred stock total equity - - - - -
Retained earnings total equity - - - 1523.82M 1371.83M
Treasury stock - -421.20300M -361.58300M -381.23800M -318.20800M
Accumulated amortization - - - - -
Non currrent assets other 411.00M 533.12M 523.79M 419.74M 279.33M
Deferred long term asset charges - - - - -
Non current assets total 2773.17M 2783.16M 2621.06M 2270.88M 2046.93M
Capital lease obligations 42.95M 51.75M 52.21M 55.28M -
Long term debt total 1052.60M 907.02M 1055.00M 1085.45M 1125.99M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -295.64200M -4.93300M -451.97800M -3.64600M -10.77900M
Change to liabilities 55.10M 52.30M 65.59M 0.92M 11.24M
Total cashflows from investing activities -295.64200M -457.23900M -451.97800M -336.26800M -735.46100M
Net borrowings 4.99M 36.95M -46.85500M -111.26400M 41.01M
Total cash from financing activities -162.09600M -81.51800M -73.72300M -197.13500M -14.87200M
Change to operating activities -28.88500M -14.15700M -10.33800M 14.41M -4.32600M
Net income 239.56M 243.64M 214.09M 242.23M 194.77M
Change in cash 19.81M -182.04500M 58.00M -19.85000M -445.81700M
Begin period cash flow 122.92M 304.97M 246.97M 266.82M 712.64M
End period cash flow 142.73M 122.92M 304.97M 246.97M 266.82M
Total cash from operating activities 478.62M 363.44M 570.15M 514.46M 313.63M
Issuance of capital stock - - - - -
Depreciation 233.71M 234.85M 220.30M 194.55M 171.75M
Other cashflows from investing activities 19.97M -1.18200M -1.14100M -90.34600M -513.43000M
Dividends paid -99.46100M -98.50900M -92.65800M -90.20800M 82.35M
Change to inventory -60.35400M -79.96100M 13.72M 0.60M -25.18300M
Change to account receivables -27.93700M -133.42000M 4.29M 21.07M -79.56000M
Sale purchase of stock -92.12600M -78.14800M 68.56M -86.49700M -61.69100M
Other cashflows from financing activities 333.41M -1.71800M 119.98M 100.11M 231.45M
Change to netincome 50.62M 54.19M 59.47M 48.97M 16.09M
Capital expenditures 315.62M 307.94M 252.05M 247.08M 211.86M
Change receivables - - - 8.81M -66.96800M
Cash flows other operating - - - 18.37M 11.94M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - -18.94600M -436.70500M
Change in working capital -44.99700M -169.69500M 76.34M 28.71M -62.47700M
Stock based compensation 40.94M 38.87M 34.15M 23.89M 19.56M
Other non cash items 21.52M 30.13M 33.47M 16.33M 13.38M
Free cash flow 163.00M 55.51M 318.11M 267.38M 101.77M


  • Previous Close 147.28
  • Market Cap8277.26M
  • Volume88142
  • P/E Ratio29.82
  • Dividend Yield1.30%
  • EBITDA665.98M
  • Revenue TTM3444.88M
  • Revenue Per Share TTM52.61
  • Gross Profit TTM 1163.84M
  • Diluted EPS TTM4.22

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AptarGroup Inc
-0.26 0.18% 147.02 29.82 26.25 2.40 3.75 2.71 14.31
Intuitive Surgical Inc
-1.25 0.31% 398.14 76.39 50.76 16.72 9.14 16.12 52.74
Essilor International SA
-0.9009 0.80% 112.24 35.39 24.81 3.63 2.20 4.00 16.25
EssilorLuxottica Société anonyme
-1.43 0.64% 222.55 35.71 25.13 3.62 2.23 4.00 16.25
Becton Dickinson and Company
0.94 0.40% 238.24 47.65 17.51 3.60 2.69 4.33 19.06

Reports Covered

Stock Research & News


AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through three segments: Aptar Pharma, Aptar Beauty, and Aptar Closures. The company provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. It also sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. In addition, the company offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company primarily sells its products and services through its own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

AptarGroup Inc

265 Exchange Drive, Crystal Lake, IL, United States, 60014

Key Executives

Name Title Year Born
Mr. Stephan B. Tanda Pres, CEO & Exec. Director 1965
Mr. Robert W. Kuhn Exec. VP & CFO 1962
Mr. Gael Touya Pres of Aptar Pharma 1970
Mr. Marc Prieur Pres of Aptar Beauty + Home 1966
Ms. Xiangwei Gong Pres of Aptar Asia 1970
Mr. Matthew DellaMaria Sr. VP of Investor Relations & Communications NA
Ms. Kimberly Y. Chainey Exec. VP, Chief Legal Officer & Corp. Sec. 1976
Ms. Shiela Pallerne Vinczeller Chief HR Officer 1964
Mr. Heidi Tlili Pres of Aptar Food + Beverage 1975

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).